approval · primary record
LUSPATERCEPT-AAMT
FDA · BLA · 2026-10-20
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-10-20 |
| Brand | REBLOZYL |
| Sponsor | CELGENE CORP |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:14.441Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LUSPATERCEPT-AAMT:2026-10-20
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.